Page 4,891«..1020..4,8904,8914,8924,893..4,9004,910..»

Treatments to Prevent Yet Another Stroke

Posted: Published on September 24th, 2013

Dear Dr. Roach: Im a 66-year-old man who has had two strokes in two years. The surgeon said that what caused the strokes both times is that arteries that supply blood to my brain are too small. The surgeon said brain surgery was too dangerous. All he did was change my meds. My concern is whether this treatment is enough to prevent another stroke. Im afraid I may have a third and final stroke! Dr. Roach, are there any other treatments available? Can this problem be helped with stents or stem cells? J.B. Answer: A stroke is very similar to a heart attack. Not enough blood flows to the brain, and some of the brain cells die, and the brain forms a scar. Depending on how much and what part of the brain is affected, the effect can be anywhere from unnoticeable to devastating. A TIA (transient ischemic attack) is similar to a stroke, except that symptoms last less than 24 hours, and it is thought to be from poor blood flow but without the resulting death of the brain cells. Treatment for an acute stroke, like a heart attack, should be done as quickly as possible in the hospital. … Continue reading →

Comments Off on Treatments to Prevent Yet Another Stroke

A personal trainer for your brain

Posted: Published on September 24th, 2013

Sep. 23, 2013 Whether you're nervous about the consequences of your teenager's concussion, you're worried about your aging parents and the anxieties associated with the threat of dementia, or your own bouts of forgetfulness, many of us are rightfully concerned about our brain health. Using the neighborhood gym as a model, Beth Israel Deaconess Medical Center's new Brain Fit Club offers members a way to support brain health by devising personalized workout routines designed to keep each member's brain limber and active. An individual Brain Fit Club workout routine might involve a combination of scientifically-validated computerized cognitive training, brain stimulation, nutritional coaching, mindfulness training, sleep and lifestyle education, gait and balance evaluation and treatment, and group classes in meditation, tai chi and gentle yoga designed to target a full range of cognitive struggles or decline. "At BIDMC we have nearly 40 years of experience in expertly diagnosing and treating disorders of cognition," says Albert Galaburda, MD, Chief of Cognitive Neurology. "Through research here and elsewhere we know that there's a lot to be gained from pairing traditional treatments like medication with special kinds of exercises, and we're very excited to offer this comprehensive approach to our patients." The concept underlying … Continue reading →

Posted in Brain Injury Treatment | Comments Off on A personal trainer for your brain

Can mild hypothermia treatment improve neuron survival after traumatic brain injury?

Posted: Published on September 24th, 2013

Public release date: 23-Sep-2013 [ | E-mail | Share ] Contact: Vicki Cohn vcohn@liebertpub.com 914-740-2100 Mary Ann Liebert, Inc./Genetic Engineering News New Rochelle, NY, September 23, 2013Moderate reductions in body temperature can improve outcomes after a person suffers a traumatic brain injury (TBI). New research that identifies positive effects of mild hypothermia on brain tissue is presented in an article published in Therapeutic Hypothermia and Temperature Management, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Therapeutic Hypothermia and Temperature Management website at http://www.liebertpub.com/ther. The article "Effects of Mild Hypothermia Treatment on Rat Hippocampal -Amyloid Expression Following Traumatic Brain Injury" coauthored by Shi-Xiang Cheng, Sai Zhang, Hong-Tao Sun, and Yue Tu, Logistics College of the Chinese People's Armed Police Forces, Tianjin, China, is part of a special issue of Therapeutic Hypothermia and Temperature Management highlighting research conducted in China. Ji-Yao Jiang, PhD, MD, Jiaotong University School of Medicine, Shanghai, is Guest Editor of the special issue. Cheng et al. compared the effects of normal temperature and hypothermia on rats with TBI. The animals treated with hypothermia had significantly improved behavioral scores and a greater number of surviving neurons compared to the normothermia group. … Continue reading →

Posted in Brain Injury Treatment | Comments Off on Can mild hypothermia treatment improve neuron survival after traumatic brain injury?

Surgeon faces probe over breast cancer treatment

Posted: Published on September 24th, 2013

Surgeon faces probe over breast cancer treatment Tuesday, September 24, 2013 A woman who died of breast cancer following a nine-month delay in her diagnosis voiced concerns about her young daughter and her will shortly before she passed away. By Kevin Keane Her consultant breast surgeon is facing allegations that he failed to carry out a full investigation on the woman, known only as Ms K. A Medical Council fitness to practise inquiry has heard the consultant initially decided not to carry out a mammogram on her and instead opted for a ultrasound and asked her to return to see him three months later. The consultant is on sick leave from work and can only be identified as Dr C, upon the direction of the inquiry. It heard that Ms K, who was aged 40 at the time, was referred to the surgeon by her GP in Jul 2007 after complaining of lumps in her left breast. Before seeing Dr C in August, she failed to attend two earlier appointments and also failed to attend a follow-up appointment made for her in Dec 2007. However, after being sent for a mammogram and biopsy by Dr C in Jun 2008, she … Continue reading →

Posted in MS Treatment | Comments Off on Surgeon faces probe over breast cancer treatment

Angelina Jolie's mastectomy surgeon Kristi Funk hits back at criticism

Posted: Published on September 24th, 2013

By Margot Peppers PUBLISHED: 14:16 EST, 23 September 2013 | UPDATED: 14:32 EST, 23 September 2013 24 shares 32 View comments Angelina Jolie's breast cancer surgeon has hit back at critics who say she's 'taking advantage' of the clients who have been flocking to her now-famous clinic. Kristi Funk, 44, told Town & Country that it was 'entirely' Ms Jolie's decision to 'go public' about the preventive double mastectomy she underwent at the Pink Lotus Breast Center, the clinic Dr Funk co-founded in Beverly Hills. 'She and Brad hope their situation can resonate with other women,' Dr Funk said of the actress. 'Whatever criticism there is that I am taking advantage of my clientele is overruled by the good that is done.' Claim to fame: Angelina Jolie's breast cancer surgeon Kristi Funk (pictured) has hit back at critics who say she's 'taking advantage' of the clients who have been flocking to her now-famous clinic Since May, when Ms Jolie told the New York Times she had her treatment at Pink Lotus, patients have been calling the clinic non-stop, booking appointments with Dr Funk up to three months in advance. See the rest here: Angelina Jolie's mastectomy surgeon Kristi Funk hits … Continue reading →

Posted in MS Treatment | Comments Off on Angelina Jolie's mastectomy surgeon Kristi Funk hits back at criticism

Surveyed U.S. Neurologists Report Greater Overall Satisfaction with Tecfidera than with Platform Injectables and Other …

Posted: Published on September 24th, 2013

EXTON, Pa., Sept.24, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds that surveyed U.S. neurologists report significantly greater overall physician satisfaction with Biogen Idec's recently-launched oral disease-modifying therapy (DMT) Tecfidera than with most other DMTs approved for the treatment of relapsing forms of multiple sclerosis (MS). These other agents include platform injectables such as interferon-beta therapies and Teva's Copaxone, as well as other oral DMTsAubagio from Genzyme (a Sanofi company) and Novartis's Gilenya. This finding likely reflects respondents' high rating of Tecfidera on several key performance attributes in the areas of efficacy and patient benefits compared with other approved agents. Nevertheless, Copaxonethe current patient share leader among respondents' DMT-treated MS patientsstill ranks as respondents' most preferred brand for the treatment of relapsing-remitting multiple sclerosis (RR-MS), a perception driven by the drug's long-term safety and tolerability/side effect profile. (Logo: http://photos.prnewswire.com/prnh/20130103/MM36805LOGO ) The recently published TreatmentTrends: Multiple Sclerosis Q3 2013 (US) report also finds that, if only two late-stage emerging products were to launch for the treatment of MS (out of six products assessed), more than 45 percent of surveyed neurologists select Teva's Copaxone 40 mg three-times-weekly (3TW) and Genzyme/Bayer … Continue reading →

Posted in MS Treatment | Comments Off on Surveyed U.S. Neurologists Report Greater Overall Satisfaction with Tecfidera than with Platform Injectables and Other …

Natural Hormone Replacement Therapy by Balanced Solutions with Steve and Cindy LeMarr – Video

Posted: Published on September 24th, 2013

Natural Hormone Replacement Therapy by Balanced Solutions with Steve and Cindy LeMarr Natural Hormone Replacement Therapy compounded with micronized yam oils and administered with pellet therapy in the upper part of the buttocks. By: BalancedSolutions NaturalHormoneReplacementTherapy … Continue reading →

Posted in Hormone Replacement Therapy | Comments Off on Natural Hormone Replacement Therapy by Balanced Solutions with Steve and Cindy LeMarr – Video

Research and Markets: Single Cell Genomics (SCG) Report 2013: Market Size, Segmentation, Growth, Competition and Trends

Posted: Published on September 24th, 2013

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/qx5lqb/single_cell) has announced the addition of the "Single Cell Genomics (SCG) Report 2013: Market Size, Segmentation, Growth, Competition and Trends" report to their offering. Single cell genomics (SCG) is a fast growing, emerging approach in which genomic technologies (i.e., that assess nucleic acids such as DNA or RNA) are applied at the level of single cells, rather than at the level of an entire cell population. The first edition of this report reviews the market size, segmentation, growth and trends of the SCG market. We assess the SCG market across 7 segments and 32 sub-segments: - Customer (academia, biopharma, applied markets, clinical) - Workflow step (cell isolation, sample preparation, genomic analysis) - Analytical technology (PCR, qPCR, microarray, next-generation-sequencing, other) - Field-of-study (oncology, basic cell biology, stem cell biology, microbiology, neurology, immunology, other) - Application (genomic variation, subpopulation characterization, circulating tumor cells, cell differentiation / reprogramming, method, other) - Product type (instruments, reagents) See more here: Research and Markets: Single Cell Genomics (SCG) Report 2013: Market Size, Segmentation, Growth, Competition and Trends … Continue reading →

Posted in Stem Cell Research | Comments Off on Research and Markets: Single Cell Genomics (SCG) Report 2013: Market Size, Segmentation, Growth, Competition and Trends

Sequenom will review genetic analysis unit options

Posted: Published on September 24th, 2013

Home Mail News Sports Finance Weather Games Groups Answers Screen Flickr More omg! Shine Movies Music TV Health Shopping Travel Autos Homes Mobile Yahoo News Search News Search Web Sign In Mail Help Account Info Help Suggestions Yahoo News Home Video Photos GMA Year in Review Odd Comics Travel Opinion Trending Now Who Knew? Weather The Upbeat U.S. U.S. Video GMA Education Religion Crimes and Trials Local Contributor Network Year In Review World World Video Middle East Europe Latin America Africa Asia Canada Australia/Antarctica Business Video Exclusives Today's Markets Stocks Personal Finance Marketplace Entertainment Video Clinton Concert Celebrity TV Movies Music Fashion Books Arts Theater Dear Abby Comics Odd News Sports Video NFL MLB NBA NCAAF NCAAB Soccer Cycling NHL Tennis Golf Boxing Motor Sports MMA Olympics Tech Gadgets Wireless Apple Social Media Security Open Source Gaming Apps This Could Be Big Upgrade Your Life Politics Remake America The Issues Women and Politics Press Releases Video Science Science Video Weather News Space / Astronomy Pets Dinosaurs / Fossils Biotech Energy Green Health Video Weight Loss Cancer Sexual Health Medications/Drugs Parenting/Kids Seniors/Aging Diseases/Conditions Blogs The Sideshow Katie's Take Power Players This Could Be Big Newsmakers Trending Now The Upbeat Who Knew? … Continue reading →

Comments Off on Sequenom will review genetic analysis unit options

Data on Cytori's Cell Therapy – Analyst Blog

Posted: Published on September 24th, 2013

Cytori Therapeutics, Inc. ( CYTX ) provided preliminary data from a study evaluating a potential treatment for scleroderma based on the company's cell therapy. The investigator-funded, open-label, pilot study is being conducted on patients with cutaneous systemic scleroderma in France. 12 patients were administered Cytori's cell therapy, injected into their fingers. Safety and hand function improvement are the primary endpoints of the study which were measured by the Cochin hand functional scale at six months. At the end of the two month follow-up period, no infection, ischemic complications or serious adverse events were observed. Moreover, there was a significant improvement in the Cochin hand function disability scale. As far as secondary endpoints are concerned, there was a significant improvement in scleroderma health assessment questionnaire score and in Raynaud's Severity Score. Also, there was a significant improvement in hand pain when measured by the visual analog pain scale. Cytori is focused primarily on the development of treatments for cardiovascular disease and soft tissue injuries and burns based on its proprietary cell therapy formulation. The company's cell therapy is based on the formulation of stem and regenerative cells derived from a patient's own adipose (fat) tissue (ADRCs). The company has also designed … Continue reading →

Comments Off on Data on Cytori's Cell Therapy – Analyst Blog

Page 4,891«..1020..4,8904,8914,8924,893..4,9004,910..»